Skip to content

Erik W. Gunderson

3 papers in the library · 254 citations · publishing 2010-2015

Papers

Sort Most recent Most cited

Designer drugs 2015: assessment and management

Addiction Science & Clinical Practice March 11, 2015 Michael F. Weaver, John A. Hopper, Erik W. Gunderson 135 citations

Recent designer drugs, also known as "legal highs," include substituted cathinones (e.g., mephedrone, methylone, and methylenedioxypyrovalerone, often referred to as "bath salts"); synthetic cannabinoids (SCs; e.g., Spice); and synthetic hallucinogens (25I-NBOMe, or N-bomb). Compound availability has evolved rapidly to evade legal regulation and detection by routine drug testing. Young adults...

A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans

Psychopharmacology June 30, 2011 M. Kirkpatrick, Erik W. Gunderson, Audrey Y. Perez et al. 119 citations

Despite their chemical similarities, methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) produce differing neurochemical and behavioral responses in animals. In humans, individual studies of methamphetamine and MDMA indicate that the drugs engender overlapping and divergent effects; there are only limited data comparing the two drugs in the same individuals. This study examined the...

Neurophysiological and cognitive effects of smoked marijuana in frequent users.

Pharmacology, biochemistry, and behavior September 2010 Carl L Hart, Aaron B Ilan, Alan Gevins et al.

Previously, we reported that acute marijuana intoxication minimally affected complex cognitive performance of daily marijuana smokers. It is possible that the cognitive tests used were insensitive to marijuana-related cognitive effects. In the current study, electroencephalographic (EEG) signals were recorded as daily marijuana users performed additional tests of immediate working memory and...